Performance

Zone 2 Cardio and Longevity: Fact-Checking the Mitochondria Claim

Zone 2 — easy, conversational cardio — builds aerobic fitness, and fitness strongly predicts lower mortality. The claim that zone 2 is uniquely best for mitochondria is contested.

Zone 2 Cardio and Longevity: Fact-Checking the Mitochondria Claim

Key takeaways

  • Zone 2 cardio is exercise at 60 to 70 percent max heart rate where you can still hold a conversation
  • Cardiorespiratory fitness predicted mortality better than smoking, diabetes or hypertension in a 2018 JAMA Network Open cohort — zone 2 is one way to build it, not the only one
  • About 150 minutes per week of moderate aerobic activity is a reasonable floor; in the big cohorts the benefit keeps rising to roughly 300 to 600 minutes, then plateaus
  • Zone 2 builds aerobic base, fat oxidation and mitochondrial efficiency — but reviews find higher intensities can drive equal or greater mitochondrial adaptations in less time
  • 'Conversational pace' is the simplest gauge — if you are gasping, you are above zone 2

What zone 2 is

Zone 2 is easy, conversational-pace aerobic exercise - roughly 60 to 70% of max heart rate, the effort where you can still talk in full sentences. It is the foundation of most endurance training and a darling of the longevity world.

In physiological terms it is the top of the intensity range below the first lactate or ventilatory threshold: the hardest pace at which muscle mitochondria clear lactate about as fast as it is produced, so blood lactate stays near resting levels and fat supplies a large share of the fuel. The heart-rate percentage is a rough proxy for that threshold, and it misses for plenty of people: in well-trained athletes the threshold usually sits at a higher share of maximum heart rate, and for anyone on a beta-blocker heart-rate zones are meaningless. Confusingly, in the three-zone model used in most training research, this same intensity is called “zone 1” (below the first threshold), which is why a “zone 2” claim and a “zone 1” study can describe the same effort.

The rock-solid part: fitness and longevity

Whatever the zone, the strongest evidence in this area is that higher cardiorespiratory fitness (VO2 max) strongly predicts lower mortality. A large 2018 study in JAMA Network Open (Mandsager et al.) found cardiorespiratory fitness was a better predictor of mortality than smoking, diabetes, or hypertension (Mandsager 2018). Building aerobic capacity is one of the most powerful health investments there is.

The size of that effect is the reason for the enthusiasm. Among 122,007 patients followed for a median of 8.4 years after a treadmill test, the least fit quarter had about five times the adjusted mortality of the fittest few percent (hazard ratio 5.04), and being below average versus above average carried the same hazard ratio (1.41) as smoking (1.41) or diabetes (1.40). There was no upper limit: the “elite” group did better than the merely “high” group, including people over 70. A meta-analysis of 33 cohorts and 102,980 healthy adults put a number on the gradient: each 1-MET increase in fitness, about the difference of running 1 km/h faster, went with 13 percent lower all-cause mortality and 15 percent fewer heart events; low versus high fitness carried a relative risk of 1.70 (Kodama 2009). The American Heart Association’s 2016 statement drew the same conclusion and proposed treating fitness as a clinical vital sign (Ross 2016).

These are observational data. People who are ill are also unfit, and no trial has randomized people to intensities for decades and counted deaths. The consistency across cohorts, the dose-response, and the biological plausibility make causation likely, but the precision of the numbers overstates what is known. Why VO2 max predicts so well is explored in VO2 max and lifespan.

The debated part: is zone 2 specifically magic?

Zone 2 reliably builds the aerobic base, fat-burning, and mitochondrial efficiency, and it is sustainable and low-injury. But the popular claim that zone 2 is uniquely optimal for mitochondria is contested - reviews note that higher intensities can drive equal or greater mitochondrial adaptations in less time (Storoschuk 2025). Zone 2 is excellent, but it is not the only road.

The 2025 narrative review, co-authored by interval-training researcher Martin Gibala, concluded that current evidence does not support zone 2 as the optimal intensity for mitochondrial or fat-oxidation capacity in the general public, and that prioritising higher intensities matters most when training time is limited. The muscle-biopsy literature it draws on says roughly this:

  • Limited work-matched comparisons within the same person suggest gains in mitochondrial content are greater after high-intensity intervals than after moderate continuous exercise; sprint intervals match continuous training despite a much smaller volume; and VO2 max rises more with intervals for a given training volume (MacInnis and Gibala 2017).
  • Training volume is the main driver of mitochondrial content, while relative intensity is the main driver of mitochondrial respiratory function, and the two often dissociate (Granata 2018). Read that as “both matter”, not “easy wins”.

Where the zone 2 story comes from is elite endurance athletes. When a month of sessions by nationally competitive junior cross-country skiers was logged by heart rate and lactate, about 75 percent were clearly below the first threshold and 15 to 20 percent above the second, with surprisingly little in between - a pattern the authors note matches observational studies of elite athletes across several sports (Seiler and Kjerland 2006). But such athletes train far more hours a week than most people can; the easy volume is what they can recover from, not proof that easy is best per hour. A nine-week randomized comparison in 48 trained endurance athletes found that a polarized split (mostly easy plus some very hard) raised VO2 peak by 11.7 percent and time to exhaustion by 17.4 percent, while high-volume and threshold-only programs improved neither (Stoggl and Sperlich 2014). The hard sessions were doing much of the work.

How much: what guidelines and the big cohorts say

The World Health Organization’s 2020 guideline asks adults for 150 to 300 minutes of moderate or 75 to 150 minutes of vigorous aerobic activity a week, or a mix, plus regular muscle-strengthening activity (Bull 2020). The cohort data behind that:

  • In 661,137 adults followed for 14 years, doing less than the minimum was still linked to 20 percent lower mortality than none; meeting it once to twice over, 31 percent lower; two to three times over, 37 percent; the benefit plateaued at three to five times the minimum (39 percent), and there was no sign of harm at ten times (Arem 2015).
  • In 116,221 US health professionals followed for 30 years, 150 to 299 weekly minutes of moderate activity carried 19 to 25 percent lower mortality and 75 to 149 minutes of vigorous activity about 19 percent lower all-cause mortality; the maximum association came at roughly 300 to 600 moderate or 150 to 300 vigorous minutes, with nothing further beyond that (Lee 2022).

Moderate and vigorous minutes are roughly interchangeable in these data, at about a two-to-one ratio. Zone 2 counts as moderate.

How to use it

  • A practical split many coaches use: most of your cardio easy (zone 2), with a smaller dose of high intensity for VO2 max.
  • Treat about 150 minutes/week of moderate activity as a floor; more aerobic base is better.
  • “Conversational pace” is the simplest gauge - if you are gasping, you are above zone 2.

What the studies used, for reference rather than prescription: the elite-athlete distribution was about three-quarters of sessions easy and one-fifth hard; the nine-week trial’s polarized group followed the same shape; and the interval formats in the mitochondrial studies ranged from repeated 30-second all-out sprints to repeated hard efforts of several minutes. A structured version of this is laid out in the polarized training guide, and the heart-health angle in cardio and heart risk.

Safety and who should check with a clinician

Moderate exercise is about as safe as health behaviours get, and the cohorts above found no harm even at very high volumes. The exceptions cluster around undiagnosed heart disease and vigorous effort. Get medical clearance before starting or intensifying if you have chest pain, pressure or unusual breathlessness on exertion, fainting or near-fainting, known heart disease, uncontrolled blood pressure, or diabetes with complications. If you take a beta-blocker or other heart-rate-lowering medicine, heart-rate zones are meaningless; use the talk test or perceived effort. In pregnancy the guidelines favour staying active, with a clinician’s input on intensity.

Where the evidence is weak

Nearly all of the longevity data are observational. The mitochondrial studies are small, short, mostly in young men, and measure biopsies rather than health outcomes; content and function measures frequently disagree. Zone definitions differ between labs (heart rate, lactate, ventilation, three-zone versus five-zone models), so “zone 2” in one study is not always “zone 2” in another. And the elite-athlete distributions are descriptions of what champions do with enormous volumes, not trials of what a person with three hours a week should do.

Bottom line

The evidence that higher aerobic fitness goes with a longer life is consistent and strong, though observational, and zone 2 is a sustainable, low-injury way to build it. Just know the “zone 2 is uniquely magical” framing is overstated - mix in some higher intensity, and remember the best zone is the one you will actually keep doing.

Related

More from SelfHacking

Longevity

Strength Training and Lifespan: 30 to 60 Minutes a Week

The lifting dose linked to longer life is far smaller than a bodybuilding split: pooled cohorts put the lowest mortality at about 30 to 60 minutes of strength work a week, on top of cardio.

Longevity

Daily Steps and Lifespan: Where the 10,000 Target Came From

Many trackers default to 10,000 steps, a figure from a Japanese slogan rather than a trial. Cohort data put the plateau at 6,000 to 8,000 steps a day after 60 and 8,000 to 10,000 before it.

Longevity

Resveratrol: Poor Absorption and Mixed Results in Human Trials

Resveratrol is poorly absorbed, and human trials show small, inconsistent metabolic effects — it can even blunt some exercise adaptations. What the trials found and what the red-wine story leaves out.

Readers

Comments

Leave a comment

Comments are reviewed before they appear.